Lv5
880 积分 2024-04-03 加入
Targeted protein degradation: from mechanisms to clinic
4天前
已完结
The targeted protein degradation landscape
13天前
已完结
Targeted protein degradation: from mechanisms to clinic
13天前
已完结
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
20天前
已完结
Radiotheranostic landscape: A review of clinical and preclinical development
26天前
已完结
Adrenal CYP11B1/2 expression in primary aldosteronism: Immunohistochemical analysis using novel monoclonal antibodies
1个月前
已完结
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies
1个月前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
1个月前
已完结
Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy
1个月前
已完结
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide
1个月前
已关闭
皖公网安备34019202002308
